Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Get concise guidance on balancing a budget amid surprises, including flexible categories and a small emergency cushion.
25,157 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...
A bold revenue target from Micron points to a surprisingly durable AI demand wave. This piece breaks down what the gu...
Artificial intelligence is reshaping data centers, elevating power needs and cooling complexity. This article explain...
Coinbase again declines to back the revamped Digital Asset Market Clarity Act, citing significant concerns as lawmake...
Bitcoin has seen wild swings, but a bold forecast remains on the table. This article breaks down why some investors b...
As Tesla faces mixed results and macro headwinds, a potential post-July 2 rally lures investors. This guide breaks do...
Berkshire Hathaway reduced its cash hoard to $373.3 billion by year-end 2025, a 2.1% drop from September, as Greg Abe...
Investors are buzzing about Oklo as the Aurora Powerhouse regulatory path becomes clearer. This piece breaks down wha...
Dell Technologies could be positioning itself as a key AI infrastructure player. This article dives into the AI drive...
If you want steady income from a single stock, think about an integrated energy company that currently yields about 4...